Clinical trials
Observational Colorectal Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 6 |
| Unknown status | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 3 |
| Bayer | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Amgen | 1 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 1 |
| AstraZeneca | 1 |
| Austrian Breast & Colorectal Cancer Study Group | 1 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| Claus Lindbjerg Andersen | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 24 |
| Ovarian Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Endocrine Gland Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.